Congratulations to our Chairman, George Netto, M.D., on receiving the third UAB School of Medicine Featured Discovery award. This initiative celebrates the important research from UAB School of Medicine faculty members, in particular those published in prominent scientific journals.  

Netto, an internationally recognized clinician-scientist, was selected for his study titled, “Non-invasive detection of urothelial cancer through the analysis of driver gene mutation and aneuploidy” (eLife, 2018; 7:e32143). Dr. Netto conducted research that found a new test for urothelial cancers, which is less invasive and more accurate.

From the announcement by Selwyn Vickers, M.D., FACS, Senior Vice President for Medicine and Dean, UAB School of Medicine:

"His study, the 'Non-invasive detection of urothelial cancer through the analysis of driver gene mutation and aneuploidy,' found that the UroSEEK test, which he and colleagues developed, combined with cytology significantly enhanced early detection for patients considered at risk for bladder cancer. The test, which uses urine, significantly reduces the need for invasive testing. 

This work highlights the remarkable advancements he and other researchers are making to translate scientific findings from the bench to the bedside at rapid speed. I’m honored to work alongside Dr. Netto, who is making tremendous strides in finding more effective and accurate ways to test for urothelial cancers. Learn more about the Featured Discovery initiative and Dr. Netto’s work here."